Biomarin Pharmaceutical Inc. - Registered Shares - BMRN - stock price prediction, stock price target, analyst ratings from 28 analysts

Biomarin Pharmaceutical Inc. - Registered Shares has a share price target of US$ 97, revenue growth forecast of 11.1%, and profit growth estimate of 59.5% for FY25, based on top 28 analyst calls.